nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrofolic acid—Methotrexate—ankylosing spondylitis	0.484	1	CrCtD
Tetrahydrofolic acid—ATIC—Methotrexate—ankylosing spondylitis	0.103	0.552	CbGbCtD
Tetrahydrofolic acid—Pemetrexed—Methotrexate—ankylosing spondylitis	0.064	0.2	CrCrCtD
Tetrahydrofolic acid—Raltitrexed—Methotrexate—ankylosing spondylitis	0.064	0.2	CrCrCtD
Tetrahydrofolic acid—Leucovorin—Methotrexate—ankylosing spondylitis	0.064	0.2	CrCrCtD
Tetrahydrofolic acid—Folic Acid—Methotrexate—ankylosing spondylitis	0.064	0.2	CrCrCtD
Tetrahydrofolic acid—Pralatrexate—Methotrexate—ankylosing spondylitis	0.064	0.2	CrCrCtD
Tetrahydrofolic acid—MTHFR—Methotrexate—ankylosing spondylitis	0.0428	0.229	CbGbCtD
Tetrahydrofolic acid—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0214	0.115	CbGbCtD
Tetrahydrofolic acid—ABCC2—Dexamethasone—ankylosing spondylitis	0.0107	0.0573	CbGbCtD
Tetrahydrofolic acid—ABCC2—Methotrexate—ankylosing spondylitis	0.00858	0.046	CbGbCtD
Tetrahydrofolic acid—MTFMT—synovial membrane of synovial joint—ankylosing spondylitis	0.00417	0.525	CbGeAlD
Tetrahydrofolic acid—ALDH1L1—tendon—ankylosing spondylitis	0.000684	0.0862	CbGeAlD
Tetrahydrofolic acid—MTFMT—tendon—ankylosing spondylitis	0.000631	0.0795	CbGeAlD
Tetrahydrofolic acid—MTHFD2—Balsalazide—Sulfasalazine—ankylosing spondylitis	0.00059	0.352	CbGdCrCtD
Tetrahydrofolic acid—AMT—tendon—ankylosing spondylitis	0.000558	0.0702	CbGeAlD
Tetrahydrofolic acid—MTHFD1—tendon—ankylosing spondylitis	0.000534	0.0672	CbGeAlD
Tetrahydrofolic acid—SHMT2—tendon—ankylosing spondylitis	0.000451	0.0568	CbGeAlD
Tetrahydrofolic acid—SHMT1—tendon—ankylosing spondylitis	0.000411	0.0517	CbGeAlD
Tetrahydrofolic acid—MTR—tendon—ankylosing spondylitis	0.000327	0.0412	CbGeAlD
Tetrahydrofolic acid—MTHFD2—Medroxyprogesterone Acetate—Methylprednisolone—ankylosing spondylitis	0.00018	0.107	CbGdCrCtD
Tetrahydrofolic acid—ABCC2—tendon—ankylosing spondylitis	0.000172	0.0216	CbGeAlD
Tetrahydrofolic acid—MTHFD1—Danazol—Prednisone—ankylosing spondylitis	0.000126	0.0754	CbGdCrCtD
Tetrahydrofolic acid—MTHFD2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	9.22e-05	0.055	CbGdCrCtD
Tetrahydrofolic acid—MTHFD2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	9.07e-05	0.0541	CbGdCrCtD
Tetrahydrofolic acid—MTHFD2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	9.07e-05	0.0541	CbGdCrCtD
Tetrahydrofolic acid—MTHFD2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	8.86e-05	0.0529	CbGdCrCtD
Tetrahydrofolic acid—MTHFD2—Fluocinolone Acetonide—Methylprednisolone—ankylosing spondylitis	8.68e-05	0.0518	CbGdCrCtD
Tetrahydrofolic acid—MTHFD2—Fluocinolone Acetonide—Dexamethasone—ankylosing spondylitis	8.55e-05	0.051	CbGdCrCtD
Tetrahydrofolic acid—MTHFD2—Fluocinolone Acetonide—Betamethasone—ankylosing spondylitis	8.55e-05	0.051	CbGdCrCtD
Tetrahydrofolic acid—MTHFD2—Fluocinolone Acetonide—Triamcinolone—ankylosing spondylitis	8.35e-05	0.0498	CbGdCrCtD
Tetrahydrofolic acid—SHMT1—Validated targets of C-MYC transcriptional activation—KIR3DL1—ankylosing spondylitis	8.14e-05	0.173	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD2—Fluocinolone Acetonide—Prednisolone—ankylosing spondylitis	7.74e-05	0.0461	CbGdCrCtD
Tetrahydrofolic acid—MTHFD2—Folate Metabolism—CRP—ankylosing spondylitis	3.63e-05	0.0773	CbGpPWpGaD
Tetrahydrofolic acid—SHMT2—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	3.38e-05	0.072	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Folate Metabolism—CRP—ankylosing spondylitis	2.9e-05	0.0618	CbGpPWpGaD
Tetrahydrofolic acid—SHMT2—Folate Metabolism—CRP—ankylosing spondylitis	2.75e-05	0.0586	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD2—Folate Metabolism—TNF—ankylosing spondylitis	1.64e-05	0.035	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Folate Metabolism—CRP—ankylosing spondylitis	1.62e-05	0.0345	CbGpPWpGaD
Tetrahydrofolic acid—SHMT2—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	1.53e-05	0.0326	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	1.51e-05	0.0322	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Folate Metabolism—TNF—ankylosing spondylitis	1.31e-05	0.028	CbGpPWpGaD
Tetrahydrofolic acid—SHMT2—Folate Metabolism—TNF—ankylosing spondylitis	1.24e-05	0.0265	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	1.23e-05	0.0263	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Folate Metabolism—CRP—ankylosing spondylitis	1.23e-05	0.0262	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—ANTXR2—ankylosing spondylitis	1.21e-05	0.0258	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Folate Metabolism—CRP—ankylosing spondylitis	1e-05	0.0214	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Selenium Micronutrient Network—CRP—ankylosing spondylitis	9.75e-06	0.0208	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Selenium Micronutrient Network—CRP—ankylosing spondylitis	7.98e-06	0.017	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—B3GNT2—ankylosing spondylitis	7.47e-06	0.0159	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Folate Metabolism—TNF—ankylosing spondylitis	7.33e-06	0.0156	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—B3GNT2—ankylosing spondylitis	7.13e-06	0.0152	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	6.83e-06	0.0146	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—ANTXR2—ankylosing spondylitis	6.76e-06	0.0144	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—B3GNT2—ankylosing spondylitis	5.97e-06	0.0127	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	5.59e-06	0.0119	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Folate Metabolism—TNF—ankylosing spondylitis	5.56e-06	0.0118	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—ANTXR2—ankylosing spondylitis	5.12e-06	0.0109	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	5.03e-06	0.0107	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Folate Metabolism—TNF—ankylosing spondylitis	4.55e-06	0.0097	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Selenium Micronutrient Network—TNF—ankylosing spondylitis	4.41e-06	0.00941	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—B3GNT2—ankylosing spondylitis	4.4e-06	0.00938	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—ANTXR2—ankylosing spondylitis	4.19e-06	0.00893	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—B3GNT2—ankylosing spondylitis	3.98e-06	0.00849	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Selenium Micronutrient Network—TNF—ankylosing spondylitis	3.61e-06	0.0077	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—B3GNT2—ankylosing spondylitis	3.33e-06	0.00711	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—B3GNT2—ankylosing spondylitis	3.02e-06	0.00643	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—HLA-A—ankylosing spondylitis	2.88e-06	0.00615	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—B3GNT2—ankylosing spondylitis	2.53e-06	0.00539	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—B3GNT2—ankylosing spondylitis	2.47e-06	0.00527	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—B3GNT2—ankylosing spondylitis	2.07e-06	0.00441	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—HLA-A—ankylosing spondylitis	1.61e-06	0.00344	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—HLA-A—ankylosing spondylitis	1.22e-06	0.0026	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—HLA-A—ankylosing spondylitis	1e-06	0.00213	CbGpPWpGaD
